0001517026-20-000002.txt : 20200817 0001517026-20-000002.hdr.sgml : 20200817 20200817162927 ACCESSION NUMBER: 0001517026-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200817 DATE AS OF CHANGE: 20200817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verratti Mark CENTRAL INDEX KEY: 0001517026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 201110518 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SATL LAKE CITY STATE: UT ZIP: 84003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-08-12 0 0000899923 MYRIAD GENETICS INC MYGN 0001517026 Verratti Mark 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 President Assurex Health Inc. Common Stock 2020-08-12 4 A 0 7467 0.0 A 86526 D Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022. By: Nathan Smith For: Mark Verratti 2020-08-17